Distribution of somatostatin in the mouse brain: effects of neonatal MSG treatment.
Immunocytochemical analysis using antisera generated against the brain peptide somatostatin (SRIF) was examined in the brain of normal mice and in mice with chemical lesions of the arcuate nucleus produced neonatally by the administration of monosodium glutamate (MSG). In the normal mouse brain, SRIF immunoreactivity was seen in perikarya of the preoptic and hypothalamic periventricular nuclei. The normal distribution of SRIF fibers was apparent in several hypothalamic nuclei including the arcuate nucleus and in the internal and external zones of the median eminence. Extrahypothalamic sites of SRIF immunoreactive neurons and fibers were also observed throughout the telencephalon. At 60 days of age, certain neuroendocrine deficiencies, including growth parameters and obesity, were apparent in MSG-treated newborn mice. Analysis of SRIF projections in the brain of MSG-treated mice demonstrated a neurotoxic effect on arcuate neurons and a loss of SRIF projections to this region as well. Other components of the SRIF system in brain appeared unaffected. SRIF fibers of the arcuate region seem to originate from neuronal perikarya of the periventricular nucleus suggesting that MSG-induced endocrine deficiencies may be due to SRIF interactions at the level of the arcuate nucleus.
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism*; D004027:Diencephalon / Q000378:metabolism; D005971:Glutamates / Q000494:pharmacology*; D013006:Growth Hormone / Q000378:metabolism; D007031:Hypothalamus / Q000187:drug effects; D008032:Limbic System / Q000378:metabolism; D009115:Muridae; D009412:Nerve Fibers / Q000187:drug effects / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D012970:Sodium Glutamate / Q000494:pharmacology*; D013004:Somatostatin / Q000378:metabolism*; D013687:Telencephalon / Q000378:metabolism
D005971:Glutamates; D013004:Somatostatin; D013006:Growth Hormone; D012970:Sodium Glutamate